Towards zero thromboembolic events after bariatric metabolic surgery

Hany, M.; Abouelnasr, A.A.; Agayby, A.S.S.; Abdelsattar, A.; Torensma, B.

doi:doi:10.1007/s11695-023-06511-8

Persistent URL of this record https://hdl.handle.net/1887/3748187

View statistics

In Collections

This item can be found in the following collections:

Medicine / Leiden University Medical Centre (LUMC)

Hany, M.; Abouelnasr, A.A.; Agayby, A.S.S.; Abdelsattar, A.; Torensma, B. (2023)

Towards zero thromboembolic events after bariatric metabolic surgery

Article / Letter to editor

Obesity increases the risk of developing venous thromboembolic disease (VTE), including deep vein thrombosis (DVT), pulmonary embolism (PE), and portomesenteric vascular thrombosis (PMVT) [1]. Despite the widespread application of laparoscopy in bariatric metabolic surgery (BMS), VTE is still encountered, with the incidence of symptomatic DVT, PE, and PMVT ranging from 0.2 to 3%, 0.1 to 2%, and 0.3% to 1%, respectively [Show more Obesity increases the risk of developing venous thromboembolic disease (VTE), including deep vein thrombosis (DVT), pulmonary embolism (PE), and portomesenteric vascular thrombosis (PMVT) [1]. Despite the widespread application of laparoscopy in bariatric metabolic surgery (BMS), VTE is still encountered, with the incidence of symptomatic DVT, PE, and PMVT ranging from 0.2 to 3%, 0.1 to 2%, and 0.3% to 1%, respectively [1, 2]. We provide a brief communication on the current evidence and guidelines derived from our opinion formulated after 15 years of practice and, thereby, postulate novel suggestions for a new regimen.
Show less

Thromboembolic

Bariatric metabolic surgery

Deep vein thrombosis

Pulmonary embolism

Porto-mesenteric vascular thrombosis

Low-molecular-weight heparin